Benefits from early trial involvement in metastatic colorectal cancer: outcomes from the phase I unit at the Sarah Cannon Research Institute UK.
- DOI
- 10.1016/j.esmogo.2024.100054
- Published
- 2024 Jun
- Container
- ESMO gastrointestinal oncology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.esmogo.2024.100054,
title = {Benefits from early trial involvement in metastatic colorectal cancer: outcomes from the phase I unit at the Sarah Cannon Research Institute UK.},
author = {Woodford R and Luo S and Ignatova E and Cammarota A and Choy J and Grochot R and Williams A and Arkenau T and Fontana E},
year = {2024},
journal = {ESMO gastrointestinal oncology},
doi = {10.1016/j.esmogo.2024.100054},
url = {https://doi.org/10.1016/j.esmogo.2024.100054}
}RIS
TY - JOUR TI - Benefits from early trial involvement in metastatic colorectal cancer: outcomes from the phase I unit at the Sarah Cannon Research Institute UK. AU - Woodford R AU - Luo S AU - Ignatova E AU - Cammarota A AU - Choy J AU - Grochot R AU - Williams A AU - Arkenau T AU - Fontana E PY - 2024 JO - ESMO gastrointestinal oncology DO - 10.1016/j.esmogo.2024.100054 UR - https://doi.org/10.1016/j.esmogo.2024.100054 ER -
APA
R, W., S, L., E, I., A, C., J, C., R, G., A, W., T, A., & E, F. (2024). Benefits from early trial involvement in metastatic colorectal cancer: outcomes from the phase I unit at the Sarah Cannon Research Institute UK.. ESMO gastrointestinal oncology. https://doi.org/10.1016/j.esmogo.2024.100054
Source records
- pubmed · retrieved 2026-09-26T21:52:29.313Z